Yale BioHaven Entrepreneurship Seminars Present Marinus Pharmaceuticals: "Reformulating for Successful Drug Development"

The Yale BioHaven Entrepreneurship Seminars series continues its spring schedule on Wednesday, February 7, featuring Marinus Pharmaceuticals, Inc. (Marinus), a new specialty pharmaceutical company dedicated to the development and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. The program will be held from 4 to 5 p.m. in the Anlyan Center Auditorium of Yale Medical School, 300 Cedar Street. Registration will begin at 3:30 p.m.